Expert operators and advisors.

24+ yrs in capital markets, $3B+ transactions. Ex-advisor and banker at Rodman & Renshaw and Ladenburg Thalmann. JD, New York Law School.

MSc Biochemistry (UBC). 10+ yrs in IVD and biotech across business development, regulatory strategy and partnerships. Published in Nature.

Finance and operations leader for early-stage startups. Former Finance Manager at Electronic Arts; Head of Finance at Xtract AI.

20+ yrs advising Fortune 50 companies. Co-Founder Solidea Capital, Director Acquis Consulting, Founding Partner Summit Holdings.

AI/ML for life sciences, widely published. PhD Bioinformatics (UBC), MS in CS (Rutgers). Formerly Recursion (Nasdaq: RXRX) and Weill Cornell.

Master's at McGill and Mila researching ML for drug discovery, biomolecular design and genetics. BSc Mathematics and Computer Science.

MSc Bioorganic Chemistry (summa cum laude). 4+ yrs in pharma as a computational chemist. Leads CADD and AI-driven protein design.

Physician and faculty at McMaster. Co-founded Cloud DX, winner of Canada's first XPRIZE for the medical tricorder. Former CSA astronaut candidate.

Founder of AKT Health. 15+ yrs in life sciences and clinical research, applying AI and deeptech to regulatory workflows. Built Impakt Health, a Japan-certified Class II SaMD.

7+ yrs investing in liquid tokens and private allocations. Co-Founder and Managing Partner, Contango Digital Assets and General Tao Ventures.

Partner and Head of Capital Markets at CMX Law, New York. 30+ yrs in capital markets, M&A and cross-border transactions. Bar: New York.

CEO of Frontier IP Group (AI/IP focus) and former founding shareholder of Exscientia. Co-founded Sigma Capital with prior investment management experience in private banking and Equitable Life.